Akrivis Technologies Competitors and Similar CompaniesClear all

Akrivis Technologies's competitors and similar companies include Horizon Discovery, Actinium Pharmaceuticals, Lionex and Medicalsystem Biotechnology.
Akrivis Technologies
Akrivis Technologies
Akrivis Technologies is a biopharmaceutical company committed to the early detection, diagnosis, and treatment of serious and life-threatening diseases.
Horizon Discovery
Horizon Discovery
Horizon Discovery Group is a company that supplies genetically defined cell lines, in vivo models, reference standards, and contract research services to academia and biopharma.
Actinium Pharmaceuticals
Actinium Pharmaceuticals
Actinium Pharmaceuticals is a biopharmaceutical company developing targeted payload immunotherapeutics for the treatment of advanced cancers.
Lionex
Lionex
Lionex is a company that produces and supplies mycobacterial antigens and monoclonal antibodies for research.
Medicalsystem Biotechnology
Medicalsystem Biotechnology
Medicalsystem Biotechnology (美康生物) is an integrated systems and healthcare service provider.
Founding Date
Founding Date
2009
Founding Date
2005
Founding Date
2000
Founding Date
N/A
Founding Date
2003
Type
Type
Private
Type
Subsidiary
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Salem, US
Locations
Waterbeach, GB HQ
Boyertown, US
Lafayette, US
St. Louis, US
Locations
New York, US HQ
Locations
Braunschweig, DE HQ
Locations
Ningbo Shi, CN HQ
Employees
Employees
2
Employees
114
Employees
2517% decrease
Employees
N/A
Employees
2,104
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
58.6 m
Valuation ($)
N/A
Valuation ($)
578.8 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
£62.9m (FY, 2019)
Revenue (est.)
$90k (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
¥1.5b (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
£12.6m (FY, 2019)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
¥972.7m (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
£52.3m (FY, 2019)
Gross profit
N/A
Gross profit
N/A
Gross profit
¥547.3m (FY, 2025)
Net income
Net income
N/A
Net income
(£4.6m) (FY, 2019)
Net income
N/A
Net income
N/A
Net income
¥61.4m (FY, 2025)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 50.2m
Total funding raised
$ 7m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Horizon Discovery
HQ
Waterbeach, GB

Horizon Discovery Group is a company that supplies genetically defined cell lines, in vivo models, reference standards, and contract research services to academia and biopharma.

View company
Actinium Pharmaceuticals
HQ
New York, US
Employees
25↓ 17% decrease

Actinium Pharmaceuticals is a biopharmaceutical company developing targeted payload immunotherapeutics for the treatment of advanced cancers.

View company
Lionex
HQ
Braunschweig, DE

Lionex is a company that produces and supplies mycobacterial antigens and monoclonal antibodies for research.

View company
Medicalsystem Biotechnology
HQ
Ningbo Shi, CN
Employees
2,104

Medicalsystem Biotechnology (美康生物) is an integrated systems and healthcare service provider.

View company